Lab Reference Library / Creatinine
Liver & Kidney
Creatinine
Cr · Serum CreatinineReference range, optimal functional medicine levels, and why creatinine is the standard kidney filtration marker, why muscle mass significantly affects its interpretation, and why cystatin C and eGFR are required alongside it for accurate kidney function assessment.
Kidney MarkerMost Searched
Standard Range (M)0.74 to 1.35 mg/dL
FM Optimal (M)0.8 to 1.1 mg/dL
Standard Range (W)0.59 to 1.04 mg/dL
Unitsmg/dL
← Back to Lab Reference Library
Category: Liver & Kidney | Also known as: Serum Creatinine, Cr | Sample: Serum (fasting not required; avoid heavy meat meal before draw)
1. What This Test Measures
Serum creatinine measures the concentration of creatinine in the bloodstream. Creatinine is a small, relatively inert molecule produced from creatine phosphate during muscle energy metabolism. Creatine phosphate is regenerated continuously in skeletal muscle, and approximately 1 to 2% is non-enzymatically converted to creatinine daily. This production occurs at a relatively constant rate proportional to total skeletal muscle mass.
Creatinine is freely filtered by the kidney glomeruli, and unlike many waste products, is not reabsorbed by the renal tubules to any significant degree. A small fraction is actively secreted by proximal tubular cells into the tubular lumen, which means creatinine slightly overestimates true GFR compared to an ideal filtration marker. Nevertheless, creatinine has been the cornerstone of kidney function assessment for decades because it is inexpensive, reliably measured, and widely available.
The fundamental clinical challenge with creatinine is that it reflects muscle mass as much as it reflects kidney function. This creates two systematic errors in opposite directions:
- Muscular individuals: naturally high creatinine from high muscle mass; may have creatinine of 1.3 to 1.5 mg/dL with completely normal kidney function; creatinine-based eGFR will underestimate their true GFR
- Sarcopenic or elderly individuals: naturally low creatinine from low muscle mass; may have creatinine of 0.7 mg/dL with eGFR of only 35 mL/min; creatinine-based eGFR will significantly overestimate their true GFR and miss clinically important kidney disease
2. Why This Test Matters
- Universal kidney function screening: creatinine is included in every comprehensive metabolic panel and is the most widely obtained kidney function marker in clinical medicine. Despite its limitations, serial creatinine trends are highly informative for tracking kidney function over time.
- eGFR calculation: serum creatinine is the input variable for the CKD-EPI equation, the most widely used eGFR formula. Every creatinine result on a standard metabolic panel automatically generates an eGFR calculation that classifies kidney function by CKD staging criteria.
- BUN/creatinine ratio interpretation: the ratio of BUN to creatinine distinguishes prerenal azotemia (dehydration, reduced blood flow) from intrinsic renal disease and guides initial management of elevated kidney markers.
- Medication dose adjustment: kidney function assessed by creatinine and eGFR determines appropriate dosing for many medications that are renally cleared, including NSAIDs, antibiotics, metformin, digoxin, lithium, and contrast agents. eGFR thresholds determine when medications must be dose-reduced or avoided.
- CKD progression monitoring: serial creatinine measurements over months and years reveal the rate of kidney function decline, which determines prognosis and intervention urgency. A creatinine rising from 1.0 to 1.4 mg/dL over 18 months has very different clinical implications than the same absolute level reached acutely.
3. Standard Lab Reference Range
| Population | Standard Range | Units |
|---|---|---|
| Men (adult) | 0.74 to 1.35 | mg/dL |
| Women (adult) | 0.59 to 1.04 | mg/dL |
These ranges vary by laboratory. A creatinine within the standard reference range does not confirm normal kidney function; it confirms that creatinine production from muscle mass and kidney clearance are in equilibrium. In sarcopenic patients, this equilibrium can occur at significantly reduced GFR.
4. Optimal Functional Medicine Range
| Creatinine Level | Functional Interpretation |
|---|---|
| Men: 0.8 to 1.1 mg/dL | Optimal: adequate muscle mass and kidney filtration in balance |
| Women: 0.6 to 0.9 mg/dL | Optimal: adequate muscle mass and kidney filtration in balance |
| Men: 1.1 to 1.35 mg/dL | High-normal: evaluate with cystatin C to distinguish muscle mass from early kidney decline |
| Men: Above 1.35 mg/dL | Elevated: kidney function evaluation required; calculate BUN/Cr ratio; check cystatin C and SDMA |
| Below 0.6 mg/dL (any sex) | Low: sarcopenia or protein malnutrition; cystatin C required for true kidney function assessment |
5. What Causes Elevated Creatinine
- Chronic kidney disease: the most clinically significant cause; progressive nephron loss from diabetes, hypertension, glomerulonephritis, or other causes reduces filtration and allows creatinine to accumulate
- Acute kidney injury (AKI): rapid onset elevation from sepsis, ischemia, nephrotoxins (NSAIDs, aminoglycosides, contrast), rhabdomyolysis, or obstruction; distinguished from CKD by acute temporal course and prior normal values
- Prerenal azotemia: dehydration or reduced renal blood flow (heart failure, sepsis, hemorrhage) reduces GFR acutely; BUN/creatinine ratio above 20 is characteristic; corrects with volume repletion
- High muscle mass: the most common non-renal cause of elevated creatinine in younger adults; creatinine of 1.3 to 1.5 mg/dL in a highly muscular man with normal cystatin C and SDMA reflects physiology, not kidney disease
- High dietary meat intake: cooked meat contains creatinine that is absorbed from the gut; a high-meat meal the day before a blood draw can transiently raise creatinine by 0.1 to 0.3 mg/dL
- Medications: trimethoprim and cimetidine competitively inhibit tubular creatinine secretion, raising serum creatinine without affecting true GFR; important to recognize when interpreting creatinine in patients on these agents
- Rhabdomyolysis: massive muscle breakdown releases creatinine (and myoglobin) simultaneously; CK is dramatically elevated; distinguish from kidney disease by clinical context and CK level
6. BUN/Creatinine Ratio: The Critical Pattern
| BUN/Cr Ratio | Interpretation | Common Causes |
|---|---|---|
| Above 20 | Prerenal azotemia: urea retained disproportionately | Dehydration, heart failure, sepsis, GI bleeding, high protein catabolism |
| 10 to 20 | Normal: proportionate BUN and creatinine elevation | Intrinsic renal disease or normal physiology |
| Below 10 | Intrinsic renal or hepatic | CKD, liver disease (reduced urea production), low protein intake, rhabdomyolysis |
7. How to Protect Kidney Function
Blood Pressure and Metabolic Control
- Blood pressure optimization: hypertension is the second most common cause of CKD progression; target below 130/80 mmHg (below 120/80 with albuminuria); ACE inhibitors and ARBs are preferred agents for their additional renoprotective effects beyond blood pressure reduction
- Blood sugar control: diabetes is the leading cause of CKD in developed countries; HbA1c below 7% is associated with significantly slower CKD progression; SGLT2 inhibitors (empagliflozin, dapagliflozin) have demonstrated direct kidney-protective effects beyond glucose lowering
- Treat underlying glomerulonephritis or autoimmune kidney disease with specialist guidance
- Manage uric acid: hyperuricemia promotes tubulointerstitial nephritis and accelerates CKD progression; target below 5.5 mg/dL
Nephrotoxin Avoidance
- NSAIDs: reduce prostaglandin-mediated afferent arteriolar dilation; chronically impair renal blood flow and accelerate CKD; avoid or minimize in any patient with reduced eGFR
- IV contrast: contrast-induced nephropathy risk rises significantly with eGFR below 60; pre-procedure hydration, N-acetylcysteine, and contrast volume minimization reduce risk
- Aminoglycoside antibiotics: directly nephrotoxic; avoid or use with careful monitoring of kidney function and drug levels
- Proton pump inhibitors: associated with tubulointerstitial nephritis and CKD in long-term use; reassess necessity regularly
- Review all medications for renal clearance; dose-adjust or avoid per eGFR thresholds
Nutrition and Lifestyle
- Adequate hydration: dehydration concentrates waste products and reduces GFR acutely; 2 to 3 liters of water daily depending on activity and climate
- Protein optimization: in established CKD (eGFR below 30), modest protein restriction (0.6 to 0.8g per kg daily) slows progression; at earlier stages, adequate protein is important to prevent sarcopenia while avoiding excess
- Dietary phosphorus and potassium management becomes important in Stage 3 to 4 CKD; specialist dietitian guidance
- Omega-3 fatty acids (2 to 4g daily): anti-inflammatory; evidence for slowing CKD progression in IgA nephropathy and diabetic nephropathy
- Smoking cessation: nicotine causes renal vasoconstriction and accelerates CKD progression independent of its cardiovascular effects
- Weight loss: obesity independently accelerates CKD through hyperfiltration injury; even modest weight loss reduces kidney stress
8. The Complete Kidney Panel: Pattern Interpretation
No kidney marker is interpreted in isolation. The five-marker pattern together reveals the location and severity of kidney dysfunction:
| Pattern | Creat | BUN | eGFR | CysC | SDMA | Interpretation |
|---|---|---|---|---|---|---|
| Early decline | Normal | Normal | 90 to 110 | 0.90 to 1.00 | 0.50 to 0.60 | Earliest detectable loss; SDMA and CysC signal before creatinine or eGFR |
| Mild CKD (Stage 2) | Borderline | Normal-high | 60 to 89 | 1.00 to 1.20 | 0.60 to 0.70 | Moderate nephron loss; address all risk factors aggressively |
| Prerenal | Elevated | Very elevated | Below 60 | Elevated | Elevated | BUN/Cr above 20; dehydration or reduced blood flow; rehydrate and recheck |
| Intrinsic CKD (Stage 3) | Elevated | Elevated | 30 to 59 | Above 1.20 | Above 0.70 | BUN/Cr 10 to 15; nephrology referral; cardiovascular risk very high |
| Muscle mass artifact | High-normal | Normal | 60 to 75 (Cr-based) | Below 0.90 | Below 0.50 | Muscular individual; CysC and SDMA normal confirm pseudo-elevation; true GFR normal |
| Sarcopenia artifact | Low-normal | Low-normal | Above 90 (Cr-based) | 0.90 to 1.10 | 0.50 to 0.65 | Frail elderly; creatinine falsely reassuring; CysC and SDMA reveal true decline |
9. Related Lab Tests
BUNBUN/Cr Ratio for Pattern Interpretation
→
eGFRCalculated from Serum Creatinine
→
Cystatin CMuscle-Independent Kidney Marker
→
SDMAEarliest Kidney Decline Marker
→
Uric AcidAccelerates CKD Progression
→
Fasting GlucoseDiabetes: Leading Cause of CKD
→
10. When Testing Is Recommended
- Standard annual metabolic panel; creatinine should be evaluated with eGFR as a pair
- Always interpret alongside BUN, cystatin C, and SDMA for the complete kidney picture
- Diabetes and hypertension monitoring; both are leading causes of CKD and require at minimum annual kidney function assessment
- Before and during NSAID, aminoglycoside, metformin, lithium, or contrast agent use
- Suspected acute kidney injury: rapid creatinine rise from baseline is the diagnostic signal
- Known CKD monitoring: frequency depends on stage (every 3 to 6 months for Stage 3 and above)
- Avoid drawing creatinine within 4 hours of a large cooked meat meal for most accurate results
11. Clinical Perspective
Clinical Perspective
Creatinine tells you what is happening with the kidneys only after you correct for what it is actually measuring, which is muscle mass. The standard metabolic panel creatinine gives me a starting point, and I use it to calculate the BUN/creatinine ratio and to get an eGFR. But in my older patients, particularly women over 65 with naturally low creatinine from sarcopenia, I have seen creatinine of 0.8 mg/dL and an eGFR calculated at 78 mL/min with a cystatin C of 1.18 and an SDMA of 0.68, meaning the actual kidney function is Stage 3a chronic kidney disease that the creatinine is completely hiding. Creatinine alone is not a kidney screen. A complete kidney panel with cystatin C, SDMA, BUN, and eGFR together is the only way to know what the kidneys are actually doing.
Brian Lamkin, DO | Founder, The Lamkin Clinic | Edmond, Oklahoma
12. Frequently Asked Questions
What is the optimal creatinine level?
In functional medicine, optimal serum creatinine is 0.8 to 1.1 mg/dL for men and 0.6 to 0.9 mg/dL for women. These ranges reflect an appropriate balance of muscle mass and kidney filtration. Values above these ranges require evaluation to distinguish high muscle mass from kidney function decline, ideally with cystatin C and SDMA to confirm which factor is driving the elevation.
What does elevated creatinine mean?
Elevated creatinine indicates that kidney filtration capacity is reduced relative to creatinine production from muscle. The most common causes are chronic kidney disease (from diabetes, hypertension, or glomerulonephritis), acute kidney injury, or prerenal azotemia from dehydration or reduced renal blood flow. High muscle mass and high dietary meat intake can also raise creatinine without kidney disease, making cystatin C the essential confirmatory test.
Why does muscle mass affect creatinine?
Creatinine is produced at a rate directly proportional to skeletal muscle mass. A highly muscular individual produces more creatinine daily and therefore has higher serum creatinine than a lean or sarcopenic individual with identical kidney function. This is the primary limitation of creatinine as a kidney filtration marker: it reflects both muscle production and kidney clearance, making it impossible to interpret without knowing the patient's body composition.
What is the BUN/creatinine ratio?
The BUN/creatinine ratio (normal 10 to 15) distinguishes prerenal from intrinsic renal causes of elevated creatinine. A ratio above 20 suggests prerenal azotemia: dehydration or reduced renal blood flow causing urea retention disproportionate to creatinine rise. A ratio of 10 to 15 suggests intrinsic renal disease. A ratio below 10 suggests liver disease (reduced urea production), low protein intake, or rhabdomyolysis.
Is creatinine enough to screen for kidney disease?
No. Creatinine alone is insufficient for comprehensive kidney screening because it is affected by muscle mass and does not rise detectably until approximately 50 to 60% of kidney filtration capacity is already lost. A complete kidney assessment requires cystatin C (muscle-independent filtration marker), SDMA (most sensitive early decline marker), BUN (for pattern interpretation), urine albumin/creatinine ratio (for early glomerular damage), and blood pressure assessment.
Content authored and clinically reviewed by Brian Lamkin, DO, founder of The Lamkin Clinic in Edmond, Oklahoma. Brian Lamkin, DO has 25+ years of experience in functional and regenerative medicine. This page reflects current functional medicine practice standards and is updated as new clinical evidence becomes available.
A normal creatinine in a frail 72-year-old may be hiding Stage 3 kidney disease.
Creatinine alone misses early kidney decline. Schedule a consultation for a complete kidney panel including cystatin C, SDMA, and urine albumin assessment.
Schedule a ConsultationMedical Disclaimer: This content is provided for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Lab interpretation should always be performed in clinical context by a qualified healthcare provider. Reference ranges and optimal targets may vary based on individual patient history, clinical presentation, and laboratory methodology. Schedule a consultation to discuss your specific results with Dr. Lamkin.